Biomarkers and 30-Year Cardiovascular Outcomes in Women. Reply No … ← Biomarkers and 30-Year Cardiovascular Outcomes in Women Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer →